Grifols SA ADR (GRFS): Next-Year EPS Estimate 29.21%
As of 2026-06-11, Grifols SA ADR (GRFS) has a next-year EPS growth estimate of 29.21%.
On 2026-06-11, analyst consensus for GRFS's next-year EPS growth shifted from 28.19% to 29.21% — a positive change of 1.02 percentage points. Current-year growth is projected at 13.29%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- EPS growth next year
- 29.21%
- EPS growth this year
- 13.29%
- EPS next quarter (est)
- N/A
- Last price
- $7.49
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 29.21% | 13.29% | N/A | $7.49 |
| 2026-06-10 | 28.19% | 15.32% | N/A | $7.32 |
| 2026-06-09 | 28.19% | 15.32% | N/A | $7.34 |
| 2026-06-08 | 28.19% | 15.32% | N/A | $7.33 |
| 2026-06-07 | 28.19% | 15.32% | N/A | $7.64 |
| 2026-06-04 | 28.19% | 15.32% | N/A | $7.58 |
| 2026-06-03 | 28.19% | 15.32% | N/A | $7.47 |
| 2026-06-02 | 28.20% | 15.41% | N/A | $7.63 |
| 2026-06-01 | 28.20% | 15.41% | N/A | $7.74 |
| 2026-05-31 | 28.20% | 15.41% | N/A | $7.85 |
| 2026-05-28 | 28.51% | 15.21% | N/A | $7.98 |
| 2026-05-27 | 28.80% | 14.50% | N/A | $8.05 |
| 2026-05-26 | 28.80% | 14.50% | N/A | $8.01 |
| 2026-05-25 | 28.80% | 14.50% | N/A | $7.98 |
| 2026-05-24 | 27.00% | 16.82% | N/A | $7.98 |
| 2026-05-21 | 27.00% | 16.82% | N/A | $8.11 |
| 2026-05-20 | 27.00% | 16.82% | N/A | $8.19 |
| 2026-05-19 | 27.00% | 16.82% | N/A | $7.84 |
| 2026-05-18 | 27.00% | 16.82% | N/A | $7.87 |
| 2026-05-17 | 27.00% | 16.82% | N/A | $7.66 |
| 2026-05-14 | 27.01% | 16.84% | N/A | $7.79 |
| 2026-05-13 | 27.64% | 16.85% | N/A | $7.68 |
| 2026-05-12 | 27.64% | 16.85% | N/A | $7.56 |
| 2026-05-11 | 27.65% | 17.54% | $0.28 | $7.80 |
| 2026-05-10 | 29.69% | 17.08% | $0.28 | $8.10 |
| 2026-05-07 | 29.80% | 17.25% | $0.27 | $8.06 |
| 2026-05-06 | 29.80% | 17.25% | N/A | $8.41 |
| 2026-05-05 | 29.80% | 17.25% | N/A | $8.27 |
| 2026-05-04 | 30.69% | 18.63% | N/A | $8.23 |
| 2026-05-03 | 30.69% | 18.63% | N/A | $8.23 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Grifols SA ADR's next-year EPS growth estimate?▾
As of 2026-06-11, Grifols SA ADR (GRFS) has a next-year EPS growth estimate of 29.21%, based on analyst consensus.
When was the latest EPS estimate revision for GRFS?▾
The most recent revision occurred on 2026-06-11, when analysts adjusted the next-year EPS growth estimate from 28.19% to 29.21%.
What sector and industry does Grifols SA ADR belong to?▾
Grifols SA ADR operates in the Healthcare sector, specifically the Drug Manufacturers - General industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. GRFS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Grifols SA ADR (GRFS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports